World's Best Scientists 2026 revealed!
Nancy F. Olivieri

Nancy F. Olivieri

Nancy F. Olivieri publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nancy F. Olivieri sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Nancy F. Olivieri D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy F. Olivieri sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Nancy F. Olivieri is affiliated with the University of Toronto in Canada and has contributed to the field of Medicine, particularly focusing on Public Health, Environmental and Occupational Health, Pharmacology, Economics and Econometrics, Genetics, and Hematology.

Their recent research publications exhibit a focus on hemoglobinopathies, pharmaceutical economics, and pharmacovigilance. Notable papers include:

  • Discrepancies in self-reported financial conflicts of interest disclosures by physicians: a systematic review, 2021, BMJ Open
  • Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study, 2021, The Lancet Global Health
  • Oxidative status in the β-thalassemia syndromes in Sri Lanka; a cross-sectional survey, 2021, Free Radical Biology and Medicine
  • Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia, 2021, Acta Haematologica
  • Knowledge, Information Sources, and Institutional Trust of Patients Regarding Medication Use in Pregnancy: A Systematic Review, 2021, Journal of Family & Reproductive Health

Their work spans several main research topics, including:

  • Pharmaceutical industry and healthcare
  • Pharmaceutical Economics and Policy
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Pharmacovigilance and Adverse Drug Reactions
  • Biomedical Ethics and Regulation
  • Healthcare cost, quality, practices

Frequent collaborators in their research projects include:

  • Abirami Kirubarajan
  • Anuja Premawardhena
  • Angela Allen
  • Sachith Mettananda
  • Vikita Mehta

Publications have appeared in diverse venues such as BMJ Open, The Lancet Global Health, Free Radical Biology and Medicine, Acta Haematologica, and the Journal of Family & Reproductive Health, reflecting a broad interdisciplinary approach.

Best Publications

  • Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

    R J Adams;V C McKie;L Hsu;B Files

  • Iron-chelating therapy and the treatment of thalassemia

    Nancy F. Olivieri;Gary M. Brittenham

  • The β-Thalassemias

    Nancy F. Olivieri

  • Survival in medically treated patients with homozygous beta-thalassemia.

    Nancy F. Olivieri;David G. Nathan;James H. MacMillan;Alan S. Wayne

  • Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment

    Martin H. Steinberg;Martin H. Steinberg;Franca Barton;Oswaldo Castro;Charles H. Pegelow

  • A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

    Maria Domenica Cappellini;Alan Cohen;Antonio Piga;Mohamed Bejaoui

  • A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

    S. P. Perrine;G. D. Ginder;D. V. Faller;G. H. Dover

  • Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions

    Olivieri Nf;Buncic;Chew E;Gallant T

  • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

    Martin H. Steinberg;William F. McCarthy;Oswaldo Castro;Samir K. Ballas

  • Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.

    Nancy F. Olivieri;Gary M. Brittenham;Christine E. McLaren;Douglas M. Templeton

  • Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

    Charles H. Pegelow;Robert J. Adams;Virgil McKie;Miguel Abboud

  • Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

    Eric Nisbet-Brown;Nancy F Olivieri;Nancy F Olivieri;Patricia J Giardina;Patricia J Giardina;Robert W Grady;Robert W Grady

  • Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

    Nancy F. Olivieri;Gary M. Brittenham;Doreen Matsui;Matitiahu Berkovitch

  • Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

    Elliott P. Vichinsky;Naomi L.C. Luban;Elizabeth Wright;Nancy Olivieri

  • Secondary Iron Overload

    James P. Kushner;John P. Porter;Nancy F. Olivieri

  • Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

    Lawrence Wolfe;Nancy Olivieri;Darlene Sallan;Steven Colan

  • Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

    John Porter;Renzo Galanello;Giuseppe Saglio;Ellis E.J. Neufeld

  • Stroke prevention trial in sickle cell anemia.

    Robert J Adams;Virgil C McKie;Don Brambilla;Elizabeth Carl

  • Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

    Maria G Vogiatzi;Eric A Macklin;Ellen B Fung;Angela M Cheung

  • Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

    Martin H. Steinberg;Franca Barton;Oswaldo Castro;Charles H. Pegelow

Frequent Co-Authors

Elliott Vichinsky
Elliott Vichinsky University of California, San Francisco
David J. Weatherall
David J. Weatherall University of Oxford
Gideon Koren
Gideon Koren Brown University
Ellis J. Neufeld
Ellis J. Neufeld Boston Children's Hospital
John B. Porter
John B. Porter University College London
John S. Waye
John S. Waye McMaster University
David H.K. Chui
David H.K. Chui Boston University
Gary M. Brittenham
Gary M. Brittenham Columbia University
David G. Nathan
David G. Nathan Harvard University
Tim E. A. Peto
Tim E. A. Peto University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring Medicine in the USA, there are a range of health care administration online degree options that can open doors to leadership and management roles in healthcare settings. These programs focus on the non-clinical aspects of healthcare, such as policy, ethics, finance, and hospital administration.

For those interested in advanced healthcare leadership, pursuing one of the cheapest mha programs can be an excellent choice. Master’s degrees in healthcare administration are designed for working professionals aiming for senior positions, blending affordability with flexibility through online learning.

Clinical professionals may consider further specialization through cheap dnp online programs. The Doctor of Nursing Practice (DNP) is a practice-focused doctorate that prepares nurses for leadership in clinical practice, policy, and education.

Alternatively, aspiring pharmacists can benefit from reputable pharmd online programs. These online doctorate tracks prepare students for licensure and clinical practice, offering a cost-effective route to a high-demand profession in pharmacy.

Best Scientists Citing Nancy F. Olivieri

Trending Scientists

Recently Published Articles